Microarrays for Reproductive Health Research

Reliable microarray analysis for relevant data insights and uncompromised results

Advances in reproductive health research have greatly expanded the capabilities of cytogenetics testing in recent years. The emergence of microarray analysis has provided us with insights into genetic risk factors and disorders which are essential to the understanding of reproductive health.

 

Thermo Fisher Scientific is dedicated to building strong partnerships with cytogenetics laboratories by offering reliable sample to insights microarray research solutions. Our onboarding support is committed to helping you all the way-from starting up to ramping up.

 

Partner with us to drive path-breaking reproductive health research.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected

      Prenatal genetic research

      Prenatal genetic testing helps clinical researchers study congenital anomalies or genetic disorders in the fetus.

      Pregnant woman in a white dress holding her belly in a field of purple flowers

      Postnatal genetic research

      Postnatal genetic testing helps clinical researchers study congenital anomalies, diseases, and developmental delays in cases following birth.

      The left side of multi-ethic faces spliced together in different boxes with various neon colored overlays

      Carrier screening research

      Carrier screening research provides genetic information that helps to determine the risk and probability of passing on an inherited genetic disorder to the future generation.

      The left side of multi-ethic faces spliced together in different boxes with various neon colored overlays

      Newborn screening research

      Newborn genetic analyses helps to study severe immunodeficiency syndrome (SCID) and spinal muscular atrophy (SMA) in newborns.

      The left side of multi-ethic faces spliced together in different boxes with various neon colored overlays
      Pastel pink, purple, and blue wavy lines

       

       

      Reproductive health benefits & workflow

      Your trusted partners from sample to insights

       

      Chromosomal microarray (CMA) is a widely used genetic analysis tool, recommended by American College of Medical Genetics (ACMG) as a first-tier test for postnatal research of unexplained developmental delay, intellectual disability, congenital anomalies, and autism spectrum disorder. The American College of Obstetricians and Gynecologists (ACOG) proposes that CMA be used as the primary prenatal genetic analysis method of choice. This is based on the major advantage of CMA over standard karyotyping in terms of increased discovery yield. CMA is used to study more genetic abnormalities than traditional cytogenetic methods such as karyotyping. CMA is an ideal platform for CNV analysis and molecular cytogenetic research. 

      Thermo Fisher Scientific offers microarray solutions with robust workflows that make it easy to obtain consistent and high-quality results. Our complete microarray platform for prenatal and postnatal research, the CytoScan Cytogenetics Suite, includes hybrid-SNP arrays, automated and manual target preparation options, fully kitted reagents, the GeneChip System 3000 instrument for array processing, and Chromosome Analysis Suite (ChAS) software for data interpretation and reporting. These tools support labs to generate accurate, high-quality data and maximize operational time.

      Reproductive Health Workflow Process Steps

      Resources

      Related pages

      For Research Use Only. Not for use in diagnostic procedures.

      GeneDx Boosts Accuracy and Efficiencies with Hybrid-SNP Arrays

      GeneDx Boosts Accuracy and Efficiencies with Hybrid-SNP Arrays

      Solving the Unsolved: Where CMA makes the difference in the era of NGS

      Solving the Unsolved: Where CMA makes the difference in the era of NGS